Both the protein expression and MFI of BCL-2 in CD4+ and CD8+ T cells were significantly higher in patients with CLL than in normal controls (NC) (Fig. 1c, d, S1b, c). Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.